QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group 期刊论文 JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 卷号: 45, 期号: 11, 页码: 2267-2274 作者:  Bu, Hualei;  Chen, Jingying;  Li, Qingshui;  Hou, Jianqing;  Wei, Yuan 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/11 BRCA  Chinese ovarian cancer patient  FIGO stage  platinum sensitivity  survival   FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner 期刊论文 INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 卷号: 52, 期号: 6, 页码: 2130-2142 作者:  Wang, Yu;  Qiu, Chunping;  Lu, Nan;  Liu, Zhaojian;  Jin, Chengjuan 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 high-grade serous ovarian carcinoma  forkhead box D1  proliferation  p21  microRNA-30a-5p  microRNA-200a-5p  prognosis   A 2-Protein Signature Predicting Clinical Outcome in High-Grade Serous Ovarian Cancer 期刊论文 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 卷号: 28, 期号: 1, 页码: 51-58 作者:  Jin, Chengjuan;  Xue, Yingfeng;  Li, Yingwei;  Bu, Hualei;  Yu, Hongfeng 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 CXCL11  HMGA2  MUC16  HGSOC  Clinical outcome   PCNA-associated factor P15(PAF), targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients 期刊论文 INTERNATIONAL JOURNAL OF CANCER, 2018, 卷号: 143, 期号: 11, 页码: 2973-2984 作者:  Jin, Chengjuan;  Liu, Zhaojian;  Li, Yingwei;  Bu, Hualei;  Wang, Yu 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 P15(PAF)  FOXM1  HGSOC  PI3K/AKT/mTOR   Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma 期刊论文 INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 卷号: 52, 期号: 6, 页码: 2041-2050 作者:  Qiu, Chunping;  Wang, Yu;  Wang, Xiao;  Zhang, Qing;  Li, Yinuo 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/11 high-grade serous carcinoma  low-grade serous carcinoma  differential  diagnosis  tumor protein 53  anterior gradient homolog 3   The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients 期刊论文 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 卷号: 27, 期号: 8 作者:  Wu, Xiaohua;  Wu, Lingying;  Kong, Beihua;  Liu, Jihong;  Yin, Rutie 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05 BRCA  Germline  Mutation  Ovarian cancer  Prevalence   The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients 期刊论文 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 卷号: 27, 期号: 8, 页码: 1650-1657 作者:  Wu, Xiaohua;  Wu, Lingying;  Kong, Beihua;  Liu, Jihong;  Yin, Rutie 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 BRCA  Germline  Mutation  Ovarian cancer  Prevalence   The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients 期刊论文 2017, 卷号: 27, 期号: 8, 页码: 1650-1657 作者:  Wu, Xiaohua;  Wu, Lingying;  Kong, Beihua;  Liu, Jihong;  Yin, Rutie 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 BRCA  Germline  Mutation  Ovarian cancer  Prevalence   Coexistence of benign struma ovarii, pseudo-Meigs\' syndrome and elevated serum CA 125: Case report and review of the literature 期刊论文 Oncology letters, 2015, 卷号: 9, 期号: 4, 页码: 1739-1742 作者:  Jin, Chengjuan;  Dong, Ruiying;  Bu, Hualei;  Yuan, Mingyuan;  Zhang, Youzhong 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/17 struma ovarii  pseudo-Meigs\' syndrome  CA 125  mature teratoma  ascites  pleural effusion